WallStreetZenWallStreetZen

NYSEMKT: CHRO
Channel Therapeutics Revenue

OverviewEarningsRevenue
DividendOwnership
Channel Therapeutics revenue was $0.00 for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q1 2025) ending on Mar 31, 2025 was $0.0, down N/A from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, CHRO annual revenue was $0.0, with N/A growth year-over-year.

CHRO revenue history

Current Revenue
$0.0
Current Earnings
-$7.4M
Current Profit Margin
0%

Be the first to know when CHRO announces revenue.

CHRO Revenue History By Year

CHRO Yearly RevenueCHRO RevenueCHRO ChangeCHRO Revenue Growth
2024-12-31$0.00N/AN/A
2023-12-31$0.00N/AN/A
2022-12-31$0.00N/AN/A
2021-12-31$0.00-$199.93k-100.00%
2020-12-31$199.93kN/AN/A

1 of 1

Channel Therapeutics Revenue FAQ

What was CHRO's revenue last quarter?

Channel Therapeutics (NYSEMKT: CHRO) reported Q1 2025 revenue of $0.00 up N/A year over year. In the same quarter last year, Channel Therapeutics's revenue was $0.00.

What was Channel Therapeutics's revenue in 2024?

Channel Therapeutics's annual revenue for the twelve months ending Dec 31, 2024 was $0.00, a N/A decrease year over year.

How much does Channel Therapeutics make in a day?

Based on Channel Therapeutics annual revenue for the past four years, CHRO makes an average of $0.00 per day.

What was Channel Therapeutics's annual revenue growth in the past year?

As of Q2 2025, Channel Therapeutics's revenue has grown null year over year. Channel Therapeutics's revenue in the past year totaled $0.00.

How much does Channel Therapeutics make in a year?

Channel Therapeutics's revenue by year for the past four years is:
  • Channel Therapeutics's revenue for the twelve months ending Dec 31, 2024 was $0.00, a N/A decrease year over year.
  • Channel Therapeutics's annual revenue for Dec 31, 2023 was $0.00, a N/A decrease from 2022.
  • Channel Therapeutics's annual revenue for 2022 was $0.00, a N/A decrease from 2021.
  • Channel Therapeutics's annual revenue for 2021 was $0.00, a 100% decrease from 2020.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.